**Trader consensus favoring "No" at 87.5% implied probability reflects the absence of any novel pathogen meeting pandemic criteria—efficient sustained human-to-human transmission, global spread potential, and high impact—within the roughly 15-month window to 2028.** Current conditions support this view: enhanced surveillance through WHO’s Pandemic Hub, genomic sequencing, and AI-driven open-source monitoring (EIOS) enable rapid detection of threats, as demonstrated by swift identification of the ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo. That event, declared a public health emergency of international concern with over 8,000 confirmed cases and 4,000+ deaths by early October 2026, remains regionally focused with low assessed global risk per WHO and CDC evaluations. Seasonal influenza activity stays low and typical, while smaller outbreaks (hantavirus clusters, Nipah) show limited transmissibility. Recent developments, including WHO’s October 2026 five-year strategy for 24-hour threat identification and post-COVID improvements in preparedness, further reduce escalation odds, though experts note funding gaps and the inherent uncertainty of zoonotic emergence. New data releases from ongoing surveillance and model updates will continue to shape sentiment.